Delivery Order SPE2DB24D1034-SPE2DB24FWBV1

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $37,679.76 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The award is not associated with a set-aside program and is part of a larger indefinite-delivery contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for the delivery of a comprehensive range of medical commodities to support...
This is a $21,848.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG tablets. The award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This...
This is a $16,470.66 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ELIQUIS 5 MG TABLET 60S. The order has an ultimate completion date of August 2, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with significant indefinite delivery contracts (IDCs) in place with DLA Troop Support Medical and the Department of Justice Federal Bureau of...
This is a $40,432.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication, with a performance period through June 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This is a $21,795.60 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a common prescription medication. The order has an ultimate completion date of August 15, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a range...
This is a $11,972.94 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product. This order is not associated with a set-aside program. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. The company holds significant...
This is a $27,322.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 24, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract...
This is a $3,854.90 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The order is for 4564299437 ELIQUIS 5 MG TABLET 60S and has an ultimate completion date of April 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
This is a $11,291.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a medication, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a $3,873.88 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a period of performance through September 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies to supply a wide range of medical commodities, including...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB24FWBV1
    Delivery Order

This is a $15,976.15 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product ELIQUIS 5 MG TABLET 60S, with a period of performance through August 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery vehicles by DLA and other agencies to supply a wide range of critical medical commodities, including specialty medications, vaccines, and medical supplies, to support military treatment facilities, veterans' healthcare, and other government healthcare programs nationwide. This contract award does not utilize any set-aside designations.

Generated 11/18/24, 9:48 AM